Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Putting adoptive T cell therapy on the path to regulatory approval

Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
Putting adoptive T cell therapy on the path to regulatory approval ( Prof Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
10 Mar 2015

Using Hsp90 inhibitors in the clinic: what have we learned?

Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom
Using Hsp90 inhibitors in the clinic: what have we learned? ( Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom )
10 Mar 2015

Radiogenomic evaluation of tumour response to targeted agents

Dr Ronald Korn - CMO and founder of Imaging Endpoints, Scottsdale, USA
Radiogenomic evaluation of tumour response to targeted agents ( Dr Ronald Korn - CMO and founder of Imaging Endpoints, Scottsdale, USA )
10 Mar 2015

Mutant-specific kinase inhibitors and TAT highlights

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
Mutant-specific kinase inhibitors and TAT highlights ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
10 Mar 2015

New drugs and targets in haematological malignancies

Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA
New drugs and targets in haematological malignancies ( Dr Renier Brentjens - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Mar 2015

Drugging the cancer genome to overcome drug resistance

Prof Paul Workman - Institute of Cancer Research, UK
Drugging the cancer genome to overcome drug resistance ( Prof Paul Workman - Institute of Cancer Research, UK )
10 Mar 2015

VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma

Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA
VEGF targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma ( Dr Rana McKay - Dana-Farber Cancer Institute, Boston, USA )
27 Feb 2015

Combination of pazopanib and paclitaxel safe in urothelial cancer

Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA
Combination of pazopanib and paclitaxel safe in urothelial cancer ( Prof Sandy Srinivas - Stanford University Medical Centre, Stanford, USA )
26 Feb 2015

Tackling renal cancer with a combination of autologous immunotherapy and sunitinib

Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA
Tackling renal cancer with a combination of autologous immunotherapy and sunitinib ( Prof Robert Figlin - Cedars-Sinai, Los Angeles, USA )
26 Feb 2015

Challenging results from mTOR inhibitors in metastatic clear cell renal cancer

Prof Thomas Powles - Barts Health, London, UK
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer ( Prof Thomas Powles - Barts Health, London, UK )
26 Feb 2015

Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction

Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
11 Feb 2015

mRCC: Real-world experience: achieving efficacy beyond clinical trials

Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA
mRCC: Real-world experience: achieving efficacy beyond clinical trials ( Dr Nizar Tannir - University of Texas M.D. Anderson Cancer Center, Houston, USA )
11 Feb 2015